Valuation (22%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -39.33 | 41.64 |
| PEG Ratio (TTM) | 7.37 | 6.38 |
| P/S Ratio (TTM) | 1.09 | 1.59 |
| P/B Ratio (TTM) | 1.71 | 5.85 |
| P/FCF Ratio (TTM) | 40.09 | 22.22 |
| Price to 5YR AVG Earnings Ratio | N/A | 46.80 |
| Price to 5YR AVG FCF Ratio | N/A | 58.73 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -2.13% | 6.14% |
| ROE (TTM) | -5.23% | 18.82% |
| Net Profit Margin (TTM) | -2.60% | 4.45% |
| ROIC 5YR AVG | N/A | 13.71% |
Growth (47%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -158.18% | 541.52% | N/A |
| Revenue | 4.92% | 34.90% | N/A |
| Net Income | -142.14% | 489.66% | N/A |
| Cash Flow | 149.17% | 23.09% | N/A |
Health (32%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.43 | 17.83 |
| Quick Ratio (TTM) | 1.43 | 17.77 |
| D/E Ratio (TTM) | 0.23 | 0.67 |
| Interest Coverage (TTM) | -4.13 | 22.82 |
| Piotroski F-Score | 2 | 7 |
| Altman Z-Score | 1.82 | 4.23 |
| LTL to 5YR AVG FCF | N/A | 6.47 |
| Shares Outstanding Growth 5YR AVG | N/A | 1.02% |